RESTORING BIOLOGICAL HARMONY
Mission, Vision and Values
At miRagen, we keep our mission and vision at the forefront of our work and believe much of our achievement comes from the emphasis we place on incorporating our core values into our day-to-day activities. By fostering a collaborative work culture, we inspire creativity which in turn accelerates the development of potentially life-enhancing discoveries.
miRagen is dedicated to improving patients’ lives through the discovery and development of innovative RNA-based therapeutics, with a specific focus on microRNAs.
Be the world leader in translating microRNA discoveries into breakthrough therapies that improve human health.
We are guided by our core values and believe our success begins with every member of the team embracing and exemplifying these in all aspects of his or her work.
MIRAGEN THERAPEUTICS PARTNERS WITH WESTWOOD & WILSHIRE TO FILL CHIEF OPERATING OFFICER
miRagen Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, has hired Lee Rauch as the new Chief Operating Officer. Rauch joins miRagen from Columbia Technology Ventures, where she served as the Executive in Residence. Prior to Columbia Tech Ventures, Rauch served as Managing Director at Cervantes Life Science Partners.
The search was successfully led by Michael Cane for Westwood & Wilshire’s Life Sciences practice.
At Westwood & Wilshire, we recognize that people are an organization’s top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Our firm has offices in Los Angeles, Silicon Valley, and Seattle, serving clients on a local, national and global basis.
Why Choose Us
WE BRING YOU LEADERS WHO SCALE COMPANIES
Our Life Sciences team partners with some of the most innovative companies on the planet across Biopharmaceuticals, Medical Device, Diagnostics and Digital Health.